Color expands Expert Oncology Network and launches Peer to Peer Expert Medical Opinion program for better care and lower costs.

Learn more
Glossary

What is Oncofertility Support?

Oncofertility support helps cancer patients understand and preserve fertility options before, during, or after cancer treatment.

Oncofertility combines oncology and fertility care. It is especially relevant when cancer treatment may affect fertility, including chemotherapy, radiation, surgery, hormone therapy, stem cell transplant, or other therapies.


Why It Matters

Cancer increasingly affects people during working and family-building years. Fertility decisions often need to happen quickly, sometimes before treatment begins, which can make the moment emotionally and logistically difficult.

Cancer treatment can affect fertility, sexual health, hormone function, pregnancy options, and family-building plans. These decisions often need to happen before treatment begins.


How oncofertility support works

Oncofertility support may include:

  • Early fertility risk discussion: Helping patients understand whether treatment may affect fertility.

  • Specialist referral: Connecting patients to reproductive endocrinology or fertility preservation specialists quickly.

  • Preservation options: Discussing options such as egg freezing, sperm banking, embryo freezing, ovarian tissue preservation, or treatment planning that may reduce fertility impact when clinically appropriate.

  • Benefits and financial guidance: Helping patients understand coverage, costs, timing, and available resources.

  • Emotional support: Supporting patients through decisions involving family planning, identity, grief, and uncertainty.

  • Post-treatment planning: Addressing fertility, pregnancy, sexual health, or hormone-related concerns after treatment.


Oncofertility Support in the Context of Employee Benefits

Employers may encounter oncofertility support through fertility benefits, cancer benefits, leave programs, behavioral health resources, or advocacy support. The challenge is timing. Fertility preservation may need to happen before treatment starts, so employees need fast guidance.

A comprehensive cancer benefit should help employees identify fertility-related questions early and connect them with the right specialists and resources.

Key Takeaways
  • Oncofertility support helps cancer patients understand fertility risks and preservation options related to treatment.

  • It matters for working-age employees who may be balancing cancer care, family planning, career, and emotional stress.

  • Color's cancer clinicians identify fertility risks early, explain how treatment may affect fertility, and initiate timely referrals to reproductive endocrinology or fertility preservation specialists.


Frequently Asked Questions

Q: When should oncofertility support happen?
A: It should happen as early as possible after diagnosis and ideally before treatment begins, since some fertility preservation options must be completed before therapy starts.deliver treatment.

Q: Who needs oncofertility support?
A: Anyone whose cancer treatment may affect fertility may benefit, including people receiving chemotherapy, radiation, surgery, hormone therapy, or stem cell transplant.

Q: Why should employers include oncofertility support in cancer benefits?
A: It supports equitable, whole-person care for employees who may be making urgent family-building decisions during cancer treatment.

Learn how Color identifies fertility risks and initiates oncofertility referrals before treatment begins.